MP54: Bladder Cancer: Non-invasive II

Monday, May 16, 2022

8:45 AM – 10:00 AM

Location: Room 228

Poster Session Moderator(s)

Tracy Downs, MD

Professor of Urology
University of Virginia
KP

Kamal Pohar, MD

The Ohio State University
Christopher Anderson, MD (he/him/his)

Associate Professor
Columbia University Iriving Medical Center

Presentations:

8:45 AM – 10:00 AM

MP54-01: Discordance Between Clinical and Pathologic Carcinoma In Situ for TURBT and Radical Cystectomy in Patients With Non-Muscle Invasive Bladder Cancer: Implications for BCG Unresponsive Clinical Trial Design and Interpretation
Poster Presenter: Manuel Ramon De Jesus Escano, MD
8:45 AM – 10:00 AM

MP54-02: Two-Year Efficacy Follow-Up of a Phase I trial of Intravesical Bacillus Calmette-Guérin Combined with Intravenous Pembrolizumab in Recurrent or Persistent High-Grade Non-Muscle-Invasive Bladder Cancer after Previous Bacillus Calmette-Guérin Treatment
Poster Presenter: Jazzmyne T. Montgomery, MD, MS
8:45 AM – 10:00 AM

MP54-03: CORE1: Phase 2, Single Arm Study of CG0070 Combined with Pembrolizumab in Patients with Non Muscle Invasive Bladder Cancer (NMIBC) Unresponsive to Bacillus Calmette-Guerin (BCG)
Poster Presenter: Roger Li, MD – H. Lee Moffitt Cancer Center
8:45 AM – 10:00 AM

MP54-04: A Phase II Study of Check Point Inhibitor, Durvalumab (MEDI4736) for Bacillus Calmette-Guerin Unresponsive Carcinoma in Situ of the Bladder
Poster Presenter: Roger Li, MD – H. Lee Moffitt Cancer Center
8:45 AM – 10:00 AM

MP54-05: Evaluating intravesical nadofaragene firadenovec and immune checkpoint blockade combination therapy in BCG-unresponsive non-muscle-invasive bladder cancer: Evidence from a phase 3 trial
Poster Presenter: Anirban Mitra, MD, PHD
8:45 AM – 10:00 AM

MP54-06: Longitudinal Health-Related Quality of Life Outcomes in Adults with Non-Muscle-Invasive Bladder Cancer Receiving a Chemoablative Gel as a Primary Treatment (Optima II: Phase 2b, single arm, open-label trial)
Poster Presenter: Angela M. Smith, MD, MS
8:45 AM – 10:00 AM

MP54-07: A urine-based molecular assay refines the risk stratification of the recent American Urological Association Guideline on Hematuria
Poster Presenter: Joep Jacobus De Jong – Erasmus MC
8:45 AM – 10:00 AM

MP54-08: Urinary comprehensive genomic profiling predicts clinical recurrence in patients undergoing surveillance for urothelial carcinoma
Poster Presenter: Keyan Salari
8:45 AM – 10:00 AM

MP54-09: Urine Comprehensive Genomic Profiling Predicts Recurrence in Patients with Non-muscle Invasive Bladder Cancer Treated with Intravesical Therapy
Poster Presenter: Goran Rac, MD
8:45 AM – 10:00 AM

MP54-10: Utility of a Urine-Based DNA Methylation Test for Surveillance in Non-muscle Invasive Bladder Cancer: A Pilot Study
Poster Presenter: Seyedeh Sanam Ladi Seyedian, MD
8:45 AM – 10:00 AM

MP54-11: The role of a DNA methylation test in the surveillance of bladder cancer: a single-center blinded prospective study
Poster Presenter: Marialaura Righetto, MD
8:45 AM – 10:00 AM

MP54-12: T1 Bladder Cancer: Comparison of the Prognostic Impact of Two Substaging Systems on Disease Recurrence and Progression and Suggestion of a Novel Nomogram
Poster Presenter: Andrea Fuschi
8:45 AM – 10:00 AM

MP54-13: The update from Bladder Cancer Italian Active Surveillance (BIAS) project for Low-Grade Bladder Tumors: Long-Term oncological outcomes of Patients under Active Surveillance
Poster Presenter: Edoardo Beatrici
8:45 AM – 10:00 AM

MP54-14: Sequential intravesical gemcitabine/docetaxel provides a durable remission in recurrent high risk NMIBC following BCG therapy
Poster Presenter: Kevin R. Melnick, II, MD
8:45 AM – 10:00 AM

MP54-15: A Multicenter Study of 2-year Outcomes Following Hyperthermia Therapy with Mitomycin C in Treating BCG Unresponsive Non-Muscle Invasive Bladder Cancer: Recirculant Hyperthermic Intravesical Chemotherapy
Poster Presenter: Andrew Stemberger, BS
8:45 AM – 10:00 AM

MP54-16: Immediate Radical Cystectomy vs. BCG Immunotherapy for T1 High Grade Non-Muscle-Invasive Bladder Cancer: an International Multicentre Collaboration
Poster Presenter: Chiara Lonati, MD
8:45 AM – 10:00 AM

MP54-17: Timing of Radical Cystectomy for BCG Failure
Poster Presenter: Patrick Hensley, MD – MD Anderson Department of Urology
8:45 AM – 10:00 AM

MP54-18: Novel therapeutic targets and potential drugs for BCG incurable non-muscle-invasive bladder cancer
Poster Presenter: zhou peng
8:45 AM – 10:00 AM

MP54-19: Protein Disulfide Isomerase as a Predictive Biomarker for Non-muscle Invasive Bladder Cancer Recurrence
Poster Presenter: Kit Yuen, MD, MA
8:45 AM – 10:00 AM

MP54-20: Role of oral pentosan polysulfate in Bacillus Calmette-Guerin therapy in patients with non-muscle-invasive bladder cancer